AlphaGo’s victory braodcast on TVIm Hun-jung/Yonhap/AP Photo via Getty Images In March 2016, Google DeepMind’s artificial intelligence system AlphaGo shocked the world. In a stunning five-match series of Go, the...

Lee Sedol faced AlphaGo in 2016AP Photo/Ahn Young-joon/Alamy The first time that AlphaGo revealed its full power, it prompted a visceral reaction. Lee Sedol, the world’s greatest player of the...

(MedPage Today) -- The FDA's top vaccine official Vinay Prasad, MD, MPH, will leave the agency for the second time in less than a year, according to an HHS spokesperson....

A federal judge handed down a decision this week in a lawsuit involving the 340B prescription drug discount program as hospitals, physicians, and drug manufacturers continue to battle over how...

A machine learning model for prediction of preeclampsia risk using routinely collected data was feasible, according to a retrospective cohort study of pregnancies in late gestation.Patients who developed preeclampsia were...

(MedPage Today) -- The use of neoadjuvant chemotherapy failed to improve disease-free survival (DFS) over upfront surgery in patients with locally advanced colon cancer, a phase III randomized trial showed....

Durable mechanical circulatory support for patients with advanced heart failure is currently limited to one left ventricular assist device.Several ventricular assist devices are in development, though few have reached larger...

NASA gave the Didymos system a nudgeSteve Gribben/Johns Hopkins APL/NASA Humanity has shifted an asteroid’s orbit around the sun for the first time. This was achieved by NASA’s Double Asteroid...

(MedPage Today) -- A promising combination for multiple myeloma received FDA approval as a second-line therapy. The approval of teclistamab (Tecvayli) plus daratumumab hyaluronidase (Darzalex Faspro) stipulates use in patients...

(MedPage Today) -- Most of America "springs forward" Sunday for daylight saving time. Losing that hour of sleep can do more than leave people tired and cranky the next day;...

(MedPage Today) -- She was 29 at the time of our visit, nearly a decade after first describing painful periods to her physician. Her worsening dysmenorrhea started in adolescence and...

Enceladus, a moon of Saturn, is a prime target in the hunt for life elsewhere in our solar systemNASA/JPL/Space Science Institute A new method to recognise the chemical properties of...

An investigational approach to diagnosis of prostate cancer uses sound waves to extract "bubbles of information" from cells. (Cancer Research UK) In a first-ever clinical trial, a treatment strategy that...

Studies in a new meta-analysis show sex differences in average weight loss, but similar benefits across other sub-groups. Medscape Medical News Source link : https://www.medscape.com/viewarticle/glp-1-weight-loss-higher-among-women-2026a10006zx?src=rss Author : Publish date :...

A first-in-class gene-regulating therapy cut seizures by up to 91% in children with Dravet syndrome in extension studies, raising hopes for a disease-modifying treatment. Medscape Medical News Source link :...

Keeping you sharp may be an unexpected, but welcome, side effect of vaccinesJozef Polc / Alamy There is growing evidence that ongoing inflammation in various parts of the body might...

A health campaigner says women's relationship to pain is shaped by the way they grow up with it as a part of their lives. Source link : https://www.bbc.com/news/videos/c99j57gkmk8o?at_medium=RSS&at_campaign=rss Author :...

(MedPage Today) -- Health Secretary Robert F. Kennedy Jr. plans to loosen restrictions on some peptides that the FDA previously prohibited compounding pharmacies from producing, he said on an episode...

(MedPage Today) -- NEW ORLEANS -- A 12-year study of Achilles tendon injuries in Major League Soccer (MLS) players found that full ruptures were uncommon but typically season-ending, and performance...

(MedPage Today) -- Obinutuzumab (Gazyva) appears set to add systemic lupus erythematosus (SLE) to its list of approved indications, as results from a phase III trial showed it was significantly...